Invention Grant
- Patent Title: Chromatographic method for isolating and purifying high-purity recombined human serum albumin
-
Application No.: US14653258Application Date: 2013-05-09
-
Publication No.: US10730926B2Publication Date: 2020-08-04
- Inventor: Daichang Yang , Bo Shi , Qianni Shi , Jiquan Ou , Jingru Liu
- Applicant: Wuhan Healthgen Biotechnology Corp
- Applicant Address: CN Hubei, Wuhan
- Assignee: WUHAN HEALTHGEN BIOTECHNOLOGY CORP
- Current Assignee: WUHAN HEALTHGEN BIOTECHNOLOGY CORP
- Current Assignee Address: CN Hubei, Wuhan
- Agency: Rimon, P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1e55d2a1
- International Application: PCT/CN2013/075405 WO 20130509
- International Announcement: WO2014/094406 WO 20140626
- Main IPC: C07K14/765
- IPC: C07K14/765 ; C07K1/16 ; C07K1/20

Abstract:
Disclosed is a chromatographic method for isolating and purifying high-purity recombined human serum albumin, comprising: conducting cation-exchange chromatography on recombined human serum albumin, and adding alcohol to a buffer solution to remove endotoxin, so as to obtain a primary product I; under binding conditions, conducting anion/hydrophobic composite resin exchange chromatography on the primary product I to obtain an intermediate product II; conducting hydrophobic chromatography on the intermediate product II to obtain the target product, the purified high-purity recombined human serum albumin. The purity of the recombined human serum albumin obtained by isolating and purifying with the chromatographic method of the present invention is greater than 99.9999%, and the content of the endotoxin meets the criteria stipulated by Chinese pharmacopoeia.
Public/Granted literature
- US20150329618A1 CHROMATOGRAPHIC METHOD FOR ISOLATING AND PURIFYING HIGH-PURITY RECOMBINED HUMAN SERUM ALBUMIN Public/Granted day:2015-11-19
Information query